SEC Form 4 · accession 0001131096-16-000233
ATHENAHEALTH INC · ATHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Kane
Director
Period of report
Jan 27, 2016
Accepted (ET)
Jan 29, 2016 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131096
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 27, 2016 | M | 2,875 | $15.27 | A | 9,008 | D | |
| Common StockF1,F2 | Jan 27, 2016 | S | 2,633 | $140.68 | D | 6,375 | D | |
| Common StockF1,F3 | Jan 27, 2016 | S | 200 | $142.01 | D | 6,175 | D | |
| Common StockF1 | Jan 27, 2016 | S | 42 | $143.00 | D | 6,133 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $15.27 | Jan 27, 2016 | M | 2,875 | D | Jul 26, 2007 | Jul 26, 2017 | Common Stock | 2,875 | 9,750 | D |
Explanation of responses
- F1The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on February 25, 2015, in accordance with Rule 10b5-1.
- F2This price represents the weighted average of sales ranging from $140.50 to $141.12. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average of sales ranging from $142.00 to $142.01. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.